We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genome Mapping Reveals Genes that Contribute to Hypertension

By LabMedica International staff writers
Posted on 18 May 2009
Cardiovascular disease researchers used advanced gene mapping techniques to search for genes directly linked to blood pressure regulation.

High blood pressure (hypertension) is a syndrome that contributes to the risk of stroke, heart attack, and kidney failure, among other conditions. More...
Approximately 30% or more of adults suffer from high blood pressure, and experts suggest that it contributes to millions of deaths worldwide each year. While factors in the environment such as diet, physical activity, and stress affect blood pressure, there is also an important genetic influence that may contribute to the likelihood of an individual developing hypertension.

To study the genetic basis for high blood pressure investigators at Johns Hopkins University (Baltimore, MD, USA) mapped the genomes of nearly 30,000 people of European descent who were participants in the [U.S.] National Institutes of Health's ARIC (Atherosclerosis Risk in Communities) project. The subjects had average systolic blood pressures ranging from 118 mmHg to 143 mmHg and average diastolic blood pressures ranging from 72 mmHg to 83 mmHg.

Results published in the May 10, 2009, online edition of the journal Nature Genetics revealed that high blood pressure was linked to a mutation in the ATP2B1 gene, which codes for a calcium pump protein. A mutation in the SH2B3 gene, which codes for a protein involved in the immune response, was also found in individuals with increased blood pressure. In some of these individuals there were also mutations in genes involved in cell growth as well as genes necessary for correct heart development.

"Strikingly, none of the genes we identified as having common variation are part of the system we know about that regulates blood pressure – the genes identified are not the ones targeted by current prescription drugs to control hypertension,” said contributing author Dr. Aravinda Chakravarti, professor of genetic medicine at Johns Hopkins University. "If we can increase the number of genes implicated in blood pressure maintenance from the current 12 to the expected 50 in the next year, our understanding of the biology will change completely.”

"Hypertension is difficult to study; it is a trait, not a disease per se unless left untreated, and many things contribute to it,” said Dr. Chakravarti. "These findings identify more pathways important for blood pressure maintenance and may lead to improvements in hypertension therapy and the formation of early detection systems.”

Related Links:
Johns Hopkins University



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: Erythrocyte Sedimentation Rate Sample Stability (Photo courtesy of ALCOR Scientific)

ESR Testing Breakthrough Extends Blood Sample Stability from 4 to 28 Hours

Erythrocyte sedimentation rate (ESR) is one of the most widely ordered blood tests worldwide, helping clinicians detect and monitor infections, autoimmune conditions, cancers, and other diseases.... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.